After numerous complaints of burns and scarring allegedly caused by the migraine patch Zecurity, Teva Pharmaceuticals Industries announced it has discontinued making the patch and it is no longer available. Zecurity is an iontophoretic transdermal system used to treat acute migraine for adults. It delivers a therapeutic dose of the active ingredient sumatriptan via a single-use, battery-powered patch wrapped around the upper arm or thigh. Since the patch hit the market in September 2015, the company has been rife with reports of skin reactions where the patch was applied. Reactions reported include severe redness, pain, skin discoloration, blistering and cracked ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.